FDx Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-19,181
| Closed | -$188K | – | 557 |
|
|
2023
Q4 | $188K | Buy |
19,181
+815
| +4% | +$7.99K | 0.01% | 656 |
|
|
2023
Q3 | $153K | Buy |
18,366
+4,378
| +31% | +$36.5K | 0.01% | 607 |
|
|
2023
Q2 | $186K | Buy |
13,988
+1,733
| +14% | +$23K | 0.01% | 721 |
|
|
2023
Q1 | $100K | Hold |
12,255
| – | – | ﹤0.01% | 731 |
|
|
2022
Q4 | $100K | Buy |
12,255
+1,177
| +11% | +$9.6K | ﹤0.01% | 731 |
|
|
2022
Q3 | $64K | Sell |
11,078
-753
| -6% | -$4.35K | ﹤0.01% | 723 |
|
|
2022
Q2 | $52K | Sell |
11,831
-980
| -8% | -$4.31K | ﹤0.01% | 800 |
|
|
2022
Q1 | $117K | Buy |
+12,811
| New | +$117K | ﹤0.01% | 808 |
|